Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
(2023) 18:e0282338
At higher doses, patients lost an average of nearly a quarter of their body weight, exceeding outcomes typically reported with current licensed treatments such as Wegovy (~15%) or Mounjaro (~20%)
Individuals may be prescribed compounded tirzepatide for various reasons, such as requiring an individualized customized dose unavailable commercially, or to maintain continuity of care
Its broad range of potential research applications has made it one of the most widely discussed peptides in regenerative medicine and peptide science
Chung B, Segrest J, Smith K, Griffin F, Brouillette C
US$ 29.03
US$ 25.22
US$ 28.74
